Vermeire S, Nitcheu J, Gineste P, Flatres A, et al. Obefazimod in Patients with Moderate-to-Severely Active Ulcerative Colitis: Efficacy and Safety Analysis from the 96-week Open-label Maintenance Phase 2b study. J Crohns Colitis 2025 May 26:jjaf074. doi: 10.1093.
PMID: 40417999